title: Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome.
abstract: Fifty percent of trauma patients who present sepsis-like syndrome do not have bacterial infections. This condition is known as systemic inflammatory response syndrome (SIRS). A unifying factor of SIRS and sepsis is cardiovascular collapse. Trauma and severe blood loss cause the release of endogenous molecules known as damage-associated molecular patterns. Mitochondrial N-formyl peptides (F-MIT) are damage-associated molecular patterns that share similarities with bacterial N-formylated peptides and are potent immune system activators. The goal of this study was to investigate whether F-MIT trigger SIRS, including hypotension and vascular collapse via formyl peptide receptor (FPR) activation. We evaluated cardiovascular parameters in Wistar rats treated with FPR or histamine receptor antagonists and inhibitors of the nitric oxide pathway before and after F-MIT infusion. F-MIT, but not nonformylated peptides or mitochondrial DNA, induced severe hypotension via FPR activation and nitric oxide and histamine release. Moreover, F-MIT infusion induced hyperthermia, blood clotting, and increased vascular permeability. To evaluate the role of leukocytes in F-MIT-induced hypotension, neutrophil, basophil, or mast cells were depleted. Depletion of basophils, but not neutrophils or mast cells, abolished F-MIT-induced hypotension. Rats that underwent hemorrhagic shock increased plasma levels of mitochondrial formylated proteins associated with lung damage and antagonism of FPR ameliorated hemorrhagic shock-induced lung injury. Finally, F-MIT induced vasodilatation in isolated resistance arteries via FPR activation; however, F-MIT impaired endothelium-dependent relaxation in the presence of blood. These data suggest that F-MIT may be the link among trauma, SIRS, and cardiovascular collapse.
authors: Department of Physiology, Georgia Regents University, Augusta, Georgia camillawenceslau@hotmail.com.
authors: Camilla Ferreira
authors: CF
authors: Wenceslau
authors: Department of Physiology, Georgia Regents University, Augusta, Georgia.
authors: Cameron G
authors: CG
authors: McCarthy
authors: Department of Physiology, Georgia Regents University, Augusta, Georgia.
authors: Theodora
authors: T
authors: Szasz
authors: Department of Physiology, Georgia Regents University, Augusta, Georgia.
authors: Styliani
authors: S
authors: Goulopoulou
authors: Department of Physiology, Georgia Regents University, Augusta, Georgia.
authors: R Clinton
authors: RC
authors: Webb
mesh_terms: D000818:Animals; D001491:Basophils / Q000187:drug effects / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005334:Fever / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D006636:Histamine Release / Q000187:drug effects; D007022:Hypotension / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology; D055370:Lung Injury / Q000139:chemically induced / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000633:toxicity*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009569:Nitric Oxide / Q000378:metabolism; D009842:Oligopeptides / Q000633:toxicity*; D017208:Rats, Wistar; D044042:Receptors, Formyl Peptide / Q000819:agonists / Q000378:metabolism; D018805:Sepsis / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D012769:Shock / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors; D014664:Vasodilation / Q000187:drug effects
chemical_list: D024101:Mitochondrial Proteins; C000598438:N-formylmethionyl-methionyl-tyrosyl-alanyl-leucyl-phenylalanine; D009842:Oligopeptides; D044042:Receptors, Formyl Peptide; D009569:Nitric Oxide; D020928:Mitogen-Activated Protein Kinases
keywords: cardiovascular collapse; mitochondrial N-formyl peptides; sepsis-like syndrome
references: Crit Care Med. 2001 Jul;29(7 Suppl):S109-16
references: 11445744
references: Trends Immunol. 2002 Nov;23(11):541-8
references: 12401407
references: Nature. 2002 Dec 19-26;420(6917):885-91
references: 12490963
references: N Engl J Med. 2003 Jan 9;348(2):138-50
references: 12519925
references: Nat Med. 2003 May;9(5):517-24
references: 12724763
references: Cardiovasc Res. 2003 Oct 15;60(1):49-57
references: 14522406
references: J Immunol. 2004 Jun 15;172(12):7734-43
references: 15187157
references: Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):706-12
references: 7881660
references: Eur J Immunol. 2005 Aug;35(8):2486-95
references: 16025565
references: J Trauma. 2007 Apr;62(4):805-11
references: 17426533
references: Am J Pathol. 2007 May;170(5):1435-44
references: 17456750
references: Nature. 2010 Mar 4;464(7285):104-7
references: 20203610
references: Shock. 2010 Jul;34(1):55-9
references: 19997055
references: J Orthop Trauma. 2010 Sep;24(9):534-8
references: 20736789
references: Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1368-76
references: 21415386
references: J Vis Exp. 2013;(73):e50062
references: 23524912
references: Ann Surg. 2013 Oct;258(4):591-6; discussion 596-8
references: 23979273
references: Med Hypotheses. 2013 Oct;81(4):532-5
references: 23890799
references: Mucosal Immunol. 2014 Jan;7(1):177-87
references: 23839065
references: J Hypertens. 2014 Mar;32(3):542-54
references: 24309491
references: Eur Heart J. 2014 May;35(18):1172-7
references: 24569027